FDA accepts NDA and grants priority review of Zuranolone from Sage Therapeutics, Biogen
Zuranolone is being evaluated as a potential 14-day, rapid-acting, once-daily, oral medication to treat major depressive disorder…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.